Hinge Health, Inc.
HNGE
$40.91
-$1.20-2.85%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 50.58% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 50.58% | -- | -- | -- | |
| Cost of Revenue | 30.97% | -- | -- | -- | |
| Gross Profit | 56.50% | -- | -- | -- | |
| SG&A Expenses | 179.88% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 168.56% | -- | -- | -- | |
| Operating Income | -1,611.15% | -- | -- | -- | |
| Income Before Tax | -4,584.28% | -- | -- | -- | |
| Income Tax Expenses | 47.42% | -- | -- | -- | |
| Earnings from Continuing Operations | -4,326.89% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -4,326.89% | -- | -- | -- | |
| EBIT | -1,611.15% | -- | -- | -- | |
| EBITDA | -1,739.89% | -- | -- | -- | |
| EPS Basic | -464.28% | -- | -- | -- | |
| Normalized Basic EPS | -1,222.37% | -- | -- | -- | |
| EPS Diluted | -465.90% | -- | -- | -- | |
| Normalized Diluted EPS | -1,197.47% | -- | -- | -- | |
| Average Basic Shares Outstanding | 303.39% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 291.27% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |